Financials
Income statement
Fiscal date | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
---|---|---|---|---|
Total reported revenue | 2.6B | 3.2B | 3.2B | 2.4B |
Cost of revenue | 1.4B | 1.7B | 1.6B | 1.3B |
Gross profit | 1.2B | 1.5B | 1.6B | 1.1B |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | — | — | — | — |
Other operating expenses | — | — | — | — |
Operating income | 497.7M | 817.3M | 891.4M | 380.1M |
Non operating interest income | ||||
Income | 29.0M | 46.9M | 17.9M | 36.6M |
Expense | 305.9M | 369.0M | 89.5M | 279.5M |
Other income expense | 33.2M | 59.7M | -55.4M | 33.2M |
Pretax income | 254.0M | 554.8M | 764.4M | 170.4M |
Tax provision | 146.6M | 48.6M | 240.3M | -89.5M |
Net income | 442.3M | 783.2M | 842.8M | 646.8M |
Basic EPS | 0.7 | 1.4 | 1.1 | 1.0 |
Diluted EPS | 0.7 | 1.4 | 1.0 | 1 |
Basic average shares | 556.2M | 555.6M | 541.3M | 540.1M |
Diluted average shares | 556.7M | 556.5M | 546.6M | 543.8M |
EBITDA | 1.1B | 1.4B | 1.4B | 918.7M |
Net income from continuing op. | 442.3M | 783.2M | 842.8M | 646.8M |
Minority interests | -39.2M | -1.7M | -266.7M | -93.7M |
Preferred stock dividends | — | — | — | — |